Vasohibin‐2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma
Open Access
- 9 May 2019
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 110 (7) , 2296-2308
Abstract
Vasohibin‐2 (VASH2) is expressed in various cancers and promotes their progression. We recently reported that pancreatic cancer patients with higher VASH2 expression show poorer prognosis. Herein, we sought to characterize the role of VASH2 in pancreatic cancer. We used LSL‐KrasG12D; LSL‐Trp53R172H; Pdx‐1‐Cre (KPC) mice, a mouse model of pancreatic ductal adenocarcinoma (PDAC), and cells isolated from them (KPC cells). Knockdown of Vash2 from PDAC cells did not affect their proliferation, but decreased their migration. When Vash2‐knockdown PDAC cells were orthotopically inoculated, liver metastasis and peritoneal dissemination were reduced, and the survival period was significantly prolonged. When KPC mice were crossed with Vash2‐deficient mice, metastasis was significantly decreased in Vash2‐deficient KPC mice. VASH2 was recently identified to have tubulin carboxypeptidase activity. VASH2 knockdown decreased, whereas VASH2 overexpression increased tubulin detyrosination of PDAC cells, and tubulin carboxypeptidase (TCP) inhibitor parthenolide inhibited VASH2‐induced cell migration. We next clarified its role in the tumor microenvironment. Tumor angiogenesis was significantly abrogated in vivo when VASH2 was knocked down or deleted. We further examined genes downregulated by Vash2 knockdown in KPC cells, and found chemokines and cytokines that were responsible for the recruitment of myeloid derived suppressor cells (MDSC). Indeed, MDSC were accumulated in PDAC of KPC mice, and they were significantly decreased in Vash2‐deficient KPC mice. These findings suggest that VASH2 plays an essential role in the metastasis of PDAC with multiple effects on both cancer cells and the tumor microenvironment, including tubulin detyrosination, tumor angiogenesis and evasion of tumor immunity.Keywords
Funding Information
- Japan Society for the Promotion of Science (Grant‐in‐Aid for Early‐Career Scientists/18K15205, Grants‐in‐Aid for Scientific Research (B) /16H0468)
This publication has 34 references indexed in Scilit:
- Parthenolide and costunolide reduce microtentacles and tumor cell attachment by selectively targeting detyrosinated tubulin independent from NF-κB inhibitionBreast Cancer Research, 2013
- The vasohibin family: a novel family for angiogenesis regulationThe Journal of Biochemistry, 2012
- Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic CancerCancer Cell, 2012
- Understanding Metastasis in Pancreatic Cancer: A Call for New Clinical ApproachesCell, 2012
- Stromal biology and therapy in pancreatic cancerGut, 2010
- Isolation of a small vasohibin-binding protein (SVBP) and its role in vasohibin secretionJournal of Cell Science, 2010
- Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesisBlood, 2009
- Isolation and Characterization of Vasohibin-2 as a Homologue of VEGF-Inducible Endothelium-Derived Angiogenesis Inhibitor VasohibinArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in miceCancer Cell, 2005
- Low expression of human tubulin tyrosine ligase and suppressed tubulin tyrosination/detyrosination cycle are associated with impaired neuronal differentiation in neuroblastomas with poor prognosisInternational Journal of Cancer, 2004